ATE256196T1 - Chimäre vektoren, die die verpackungsregion eines phagengenoms und einen teil des genoms eines eukaryontischen virus enthalten - Google Patents
Chimäre vektoren, die die verpackungsregion eines phagengenoms und einen teil des genoms eines eukaryontischen virus enthaltenInfo
- Publication number
- ATE256196T1 ATE256196T1 AT98929010T AT98929010T ATE256196T1 AT E256196 T1 ATE256196 T1 AT E256196T1 AT 98929010 T AT98929010 T AT 98929010T AT 98929010 T AT98929010 T AT 98929010T AT E256196 T1 ATE256196 T1 AT E256196T1
- Authority
- AT
- Austria
- Prior art keywords
- genome
- eukaryontic
- virus
- vectors containing
- packaging region
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10344—Chimeric viral vector comprising heterologous viral elements for production of another viral vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10311—Siphoviridae
- C12N2795/10341—Use of virus, viral particle or viral elements as a vector
- C12N2795/10344—Chimeric viral vector comprising heterologous viral elements for production of another viral vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/40—Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source
- C12N2810/405—Vectors comprising RGD peptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/005—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/55—Vector systems having a special element relevant for transcription from bacteria
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4907297P | 1997-06-09 | 1997-06-09 | |
US7222298P | 1998-01-22 | 1998-01-22 | |
PCT/US1998/012158 WO1998056937A2 (en) | 1997-06-09 | 1998-06-09 | Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE256196T1 true ATE256196T1 (de) | 2003-12-15 |
Family
ID=26726837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98929010T ATE256196T1 (de) | 1997-06-09 | 1998-06-09 | Chimäre vektoren, die die verpackungsregion eines phagengenoms und einen teil des genoms eines eukaryontischen virus enthalten |
Country Status (6)
Country | Link |
---|---|
US (2) | US6440728B1 (de) |
EP (1) | EP0996735B1 (de) |
AT (1) | ATE256196T1 (de) |
AU (1) | AU8067698A (de) |
DE (1) | DE69820450T2 (de) |
WO (1) | WO1998056937A2 (de) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU749856B2 (en) * | 1997-09-23 | 2002-07-04 | Genvec, Inc. | Plasmids for construction of eukaryotic viral vectors |
EP1118670A1 (de) * | 1999-12-07 | 2001-07-25 | Genethon III | Hunde-Adenovirusvektoren für den Transfer von Genen in Zielzellen |
WO2001042481A2 (en) * | 1999-12-07 | 2001-06-14 | Genethon Iii | Canine adenovirus vectors for the transfer of genes into target cells |
WO2001059071A2 (en) * | 2000-02-09 | 2001-08-16 | Genvec, Inc. | Methods of preparing and using a viral vector library |
IT1318704B1 (it) * | 2000-09-22 | 2003-08-27 | Consorzio Interuniversitario P | Vettori chimerici e loro uso per il trasferimento di geni eterologhi. |
US6573092B1 (en) | 2000-10-10 | 2003-06-03 | Genvec, Inc. | Method of preparing a eukaryotic viral vector |
FR2820146B1 (fr) * | 2001-01-29 | 2003-06-27 | Centre Nat Rech Scient | Procede d'obtention de cellules d'encapsidation fortement productrices de retrovirus par elimination, au sein de la culture, des cellules permissives a l'infection par le retro virus produit |
US20040166091A1 (en) * | 2003-02-24 | 2004-08-26 | Genvec, Inc. | Materials and methods for treating disorders of the ear |
EP1649028B1 (de) * | 2003-07-25 | 2012-08-22 | Genvec, Inc. | Adenoviralevektoren-basierte impfstoffe |
ES2340038T3 (es) * | 2003-11-14 | 2010-05-28 | Genvec, Inc. | Composicion farmaceutica para tratar cancer de pancreas localmente avanzado (cpla) no extirpable. |
CA2563396A1 (en) | 2004-04-12 | 2005-11-24 | The Government Of The United States Of America, As Represented By The Se Cretary, Department Of Health And Human Services | Method of using adenoviral vectors to induce an immune response |
CA2589602A1 (en) * | 2004-09-01 | 2006-04-13 | Genvec, Inc. | Adenoviral vectors able to transduce apcs, potential use in immune response generation |
SI2567976T1 (sl) | 2005-03-23 | 2017-11-30 | Genmab A/S | Protitelesa usmerjena proti cd38 za zdravljenje multiplega mieloma |
EP1951297A2 (de) | 2005-11-10 | 2008-08-06 | GenVec, Inc. | Adenoviraler vektorbasierter impfstoff für die maul- und klauen-seuche |
DK2222697T3 (da) | 2007-11-01 | 2013-03-11 | Perseid Therapeutics Llc | Immunsuppressive polypeptider og nukleinsyrer |
US9605844B2 (en) * | 2009-09-01 | 2017-03-28 | Cree, Inc. | Lighting device with heat dissipation elements |
CA2779632C (en) | 2009-11-09 | 2019-08-20 | Jason Gall | Simian adenovirus and methods of use |
KR20180108886A (ko) | 2010-03-23 | 2018-10-04 | 인트렉손 코포레이션 | 치료적 단백질을 조건부로 발현하는 벡터,상기 벡터를 포함하는 숙주 세포 및 이의 용도 |
CN103237889B (zh) * | 2010-08-16 | 2017-04-05 | 萨克生物研究学院 | 腺病毒组装方法 |
SG10201600912SA (en) | 2011-03-04 | 2016-03-30 | Intrexon Corp | Vectors conditionally expressing protein |
AU2014236207B2 (en) | 2013-03-14 | 2019-05-23 | Salk Institute For Biological Studies | Oncolytic adenovirus compositions |
EA201790533A1 (ru) | 2014-09-07 | 2017-07-31 | Селекта Байосайенсиз, Инк. | Способы и композиции для ослабления иммунных ответов против вирусного вектора для переноса, предназначенного для модулирования экспрессии генов |
TWI710635B (zh) | 2014-10-09 | 2020-11-21 | 美商珍維克公司 | 編碼人類無調同源物-1(hath1)之腺病毒載體 |
CA3013637A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | High throughput assay for measuring adenovirus replication kinetics |
CN117384961A (zh) | 2016-02-23 | 2024-01-12 | 萨克生物研究学院 | 对病毒动力学影响最小的治疗性腺病毒中的外源基因表达 |
WO2018111767A1 (en) | 2016-12-12 | 2018-06-21 | Salk Institute For Biological Studies | Tumor-targeting synthetic adenoviruses and uses thereof |
KR20190104194A (ko) | 2017-01-07 | 2019-09-06 | 셀렉타 바이오사이언시즈, 인크. | 합성 나노담체에 커플링된 면역억제제의 패턴화된 투여 |
CN111542336A (zh) | 2017-10-13 | 2020-08-14 | 西莱克塔生物科技公司 | 用于减弱抗病毒转移载体igm应答的方法和组合物 |
EP3962537A1 (de) | 2019-04-28 | 2022-03-09 | Selecta Biosciences, Inc. | Verfahren zur behandlung von subjekten mit vorbestehender immunität gegen virusübertragungsvektoren |
CA3141863A1 (en) | 2019-05-28 | 2020-12-03 | Selecta Biosciences, Inc. | Methods and compositions for attenuated anti-viral transfer vector immune response |
US20230141563A1 (en) | 2021-10-12 | 2023-05-11 | Selecta Biosciences, Inc. | Methods and compositions for attenuating anti-viral transfer vector igm responses |
WO2023172624A1 (en) | 2022-03-09 | 2023-09-14 | Selecta Biosciences, Inc. | Immunosuppressants in combination with anti-igm agents and related dosing |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6027722A (en) * | 1990-10-25 | 2000-02-22 | Nature Technology Corporation | Vectors for gene transfer |
FR2727689A1 (fr) * | 1994-12-01 | 1996-06-07 | Transgene Sa | Nouveau procede de preparation d'un vecteur viral |
US5736388A (en) * | 1994-12-30 | 1998-04-07 | Chada; Sunil | Bacteriophage-mediated gene transfer systems capable of transfecting eukaryotic cells |
FR2730504B1 (fr) * | 1995-02-13 | 1997-03-28 | Rhone Poulenc Rorer Sa | Procede de preparation de genomes d'adenovirus recombinants |
US5801030A (en) * | 1995-09-01 | 1998-09-01 | Genvec, Inc. | Methods and vectors for site-specific recombination |
-
1998
- 1998-06-09 DE DE69820450T patent/DE69820450T2/de not_active Expired - Fee Related
- 1998-06-09 AU AU80676/98A patent/AU8067698A/en not_active Abandoned
- 1998-06-09 WO PCT/US1998/012158 patent/WO1998056937A2/en active IP Right Grant
- 1998-06-09 AT AT98929010T patent/ATE256196T1/de not_active IP Right Cessation
- 1998-06-09 EP EP98929010A patent/EP0996735B1/de not_active Expired - Lifetime
-
1999
- 1999-11-30 US US09/450,972 patent/US6440728B1/en not_active Expired - Lifetime
-
2002
- 2002-06-03 US US10/162,043 patent/US7070930B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0996735B1 (de) | 2003-12-10 |
DE69820450D1 (de) | 2004-01-22 |
AU8067698A (en) | 1998-12-30 |
US7070930B2 (en) | 2006-07-04 |
WO1998056937A2 (en) | 1998-12-17 |
US20030170899A1 (en) | 2003-09-11 |
DE69820450T2 (de) | 2004-05-27 |
EP0996735A2 (de) | 2000-05-03 |
US6440728B1 (en) | 2002-08-27 |
WO1998056937A3 (en) | 1999-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE256196T1 (de) | Chimäre vektoren, die die verpackungsregion eines phagengenoms und einen teil des genoms eines eukaryontischen virus enthalten | |
EP0710288A4 (de) | Adenovirale vektoren für die behandlung der hämophilie | |
ATE466931T1 (de) | Verbesserte adenovirusvektoren | |
AU9338598A (en) | Recombinant vector containing infectious, viral genome sequences greater than 100 kb, method for producing same and use for the mutagenesis of the viral sequences | |
ATE270342T1 (de) | Endosomolytisch wirksame partikel | |
ES8306797A1 (es) | Un metodo para producir un polipeptido. | |
NZ504214A (en) | Recombination cloning using nucleic acids having recombination sites | |
DE60215461D1 (de) | Serpin von bifidobakterien | |
AU9254801A (en) | Methods for treating cell proliferative disorders and viral infections | |
DE69433592D1 (de) | Die erzielung hoher titer des rekombinanten aav-vektors | |
FR2710074B1 (fr) | Gène GRB3-3, ses variants et leurs utilisations. | |
DK0843731T3 (da) | Adenovirusvektorer til genterapi | |
IL117194A0 (en) | Amplifying sequences vectors comprising them and their uses in compositions for the expression of nucleotide sequences and pharmaceutical compositions containing them | |
ES2079348T3 (es) | Procedimiento de estabilizacion de un plasmido contenido en una cepa bacteriana y cepa obtenida. | |
AU2002320773A1 (en) | Vector for site-specific integration of heterologous dna sequences into the rdn a sites of methylotrophic yeasts | |
AU1099697A (en) | Novel xylanases, genes encoding them, and uses thereof | |
HIROCHIKA et al. | CONSTRUCTION AND CHARACTERIZATION OF φ105 SPECIALIZED TRANSDUCING PHAGES CARRYING SPORULATION GENES spoOB AND spoOF OF BACILLUS SUBTILIS | |
ES2171657T3 (es) | Vector de dna recombinante para terapia genica. | |
ATE277186T1 (de) | Zusammensetzung von transdominanten varianten von virus- proteinen zur antiviralen wirkung | |
RU94030484A (ru) | Плазмида, вектор, микроорганизм, лактобациллы, применение плазмиды и вектора |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |